Filing Details

Accession Number:
0001127602-19-034630
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-12-09 19:27:02
Reporting Period:
2019-12-06
Accepted Time:
2019-12-09 19:27:02
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1682852 Moderna Inc. MRNA () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1643746 H. Lorence Kim C/O Moderna, Inc.
200 Technology Square
Cambridge MA 02139
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-12-06 229,357 $20.64 1,371,684 No 4 M Direct
Common Stock Acquisiton 2019-12-06 229,358 $20.64 1,601,042 No 4 M Direct
Common Stock Disposition 2019-12-06 89,698 $19.34 1,511,344 No 4 S Direct
Common Stock Disposition 2019-12-06 147,528 $20.39 1,363,816 No 4 S Direct
Common Stock Disposition 2019-12-06 1,306 $20.93 1,362,510 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Units Disposition 2019-12-06 229,357 $0.00 229,357 $0.00
Common Stock Restricted Stock Units Disposition 2019-12-06 229,358 $0.00 229,358 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 M Direct
0 No 4 M Direct
Footnotes
  1. This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on 12/28/2018, and amended on September 17, 2019. The sale was made to generate proceeds to cover the tax liability incident to the delivery of restricted stock units.
  2. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.86 to $19.85. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
  3. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $19.87 to $20.86. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
  4. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $20.92 to $20.97. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
  5. These Restricted Stock Units are fully vested and settled in accordance with their terms.